AUG 19, 2016 12:33 PM PDT

Potential Way to Redirect the Course of Huntington's Disease

WRITTEN BY: Xuan Pham
The most intricate man-made origami structure may pale in comparison to the body’s natural origamis: 3-dimenstional proteins. The folding of amino acids in specific arrangements create highly sophisticated proteins in composition, structure, and also function.
 
When this orchestrated process goes right, human biology is a well-oiled machine. However, when the folding is off even for just a little bit, the results can be devastating. In the case of Huntington’s disease, the huntingtin protein is misfolded causing the proteins to clump in the brain. These turn into toxic clusters that interfere with the function of neurons and leading to the mental and physical decline in patients.
 
How scientists plan to remove harmful proteins to treat Huntington's | Image: pixabay.com

The neurodegeneration is progressive and fatal, with no cure yet available. But now, scientists at the Gladstone Institute may be on the verge of a therapeutic target that could reduce the toxic protein clusters in the brain. The results are promising in mice, and if it works in human too, this could be the first treatment option that would alter the course of Huntington’s disease.
 
The key to stopping misfolded huntingtin protein from clumping appears to involve a protein modification, known as phosphorylation. This process adds a chemical tag on proteins that "… helps control how proteins fold and the systems in cells that clear proteins," explained Steve Finkbeiner, who led the investigation at Gladstone.
 
By adding a phosphorylation tag on a specific amino acid residue on the protein (Serine 421), Finkbeiner’s team showed that the course of Huntington’s disease in a mouse model was positively altered.
 
"I was shocked at the profound effect phosphorylation had on the Huntington's model mice," said Ian Kratter, first author of the study. "They showed few signs of the motor dysfunction, depression, or anxiety that are characteristic of the disease. In most of our tests, they were virtually indistinguishable from healthy mice."
 

How does phosphorylation of the protein protect against the progression of Huntington’s? The team thinks this chemical modification seems to correct the misfolding to a certain degree, enough so that they don’t clump together and neurons can more easily get rid of these proteins in the brain.
 
"This is exciting, because a lot of the work we've done points to these protein removal pathways as being important not only for Huntington's disease, but also for other neurodegenerative disorders. Understanding how phosphorylation links to these pathways could help treat several different brain diseases,” said Finkbeiner.
 
Among the next big challenges is finding finding a drug that can either trigger phosphorylation of the protein, or mimic its effects.

Additional source: Gladstone Institute press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 07, 2019
Clinical & Molecular DX
AUG 07, 2019
Hepatitis A Causes Public Health Crisis In Florida
Although highly contagious, Hepatitis A is considered a rare disease. It has largely been controlled through immunizations. That said, in Florida, Hepatiti...
SEP 17, 2019
Clinical & Molecular DX
SEP 17, 2019
An All-Inclusive Genetic Testing Made Easy for the Prospective Parents
An increasing number of parents are opting their babies in for at-home genetic testing. These at-home ...
SEP 26, 2019
Cannabis Sciences
SEP 26, 2019
Arthritis Foundation Gives Cautious Thumbs Up for CBD Use
After a national survey in July confirmed that the vast majority of arthritis patients were either interested in using CBD for symptom relief or already us...
OCT 18, 2019
Clinical & Molecular DX
OCT 18, 2019
AcroMetrix BCR-ABL External Molecular Panel: An Accurate Testing Method for Chronic Myeloid Leukemia
To support the validation and verification of new assays in oncology testing, Thermo Fisher Scientific with AcroMetrix control products provides innov...
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the other hand, refers to inflammation of...
JAN 15, 2020
Clinical & Molecular DX
JAN 15, 2020
Laser microchip picks up cancer markers in urine
A future where patients no longer need to endure expensive, painful and complicated cancer tests could soon become a reality. Researchers have developed a...
Loading Comments...